CER-1236
IND- Indications
- Acute myeloid leukemia, Mantle cell lymphoma, Chronic lymphocytic leukemia, B cell neoplasms, Myeloid neoplasms
Company intelligence / Profile preview
Alesco has developed proprietary formulations using its patented Sucrosomial® Technology to enhance the bioavailability and tolerability of minerals such as iron. Its flagship product line includes the award-winning Sideral® r.m. (Sucrosomial® Iron), recognized for innovation in ingredient delivery. The company continues to expand applications to other minerals and vitamins. Clinical results are referenced by industry recognition but specific trial data not detailed in public sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alesco.